Hologic (NASDAQ:HOLX) Now Covered by Stephens

Analysts at Stephens began coverage on shares of Hologic (NASDAQ:HOLX – Get Free Report) in a research note issued to investors on Thursday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $87.00 price target on the medical equipment provider’s stock. Stephens’ price objective suggests a potential upside of 17.17% from the stock’s […]

Leave a Reply

Your email address will not be published.

Previous post Ultralife (NASDAQ:ULBI) PT Raised to $14.00
Next post Verona Pharma (NASDAQ:VRNA) Given New $36.00 Price Target at HC Wainwright